$0.194
0[0.00%]
At close: Dec 29
Vyant Bio Inc
(OTC:VYNT)Latest News for Vyant Bio Inc Stock (OTC:VYNT)
Vyant Bio Inc Stock (OTC: VYNT)
Categories: All
Friday, May 12, 2023
Thursday, May 11, 2023
- Why Groupon Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionLisa Levin - May 11, 2023, 1:46PM
- 12 Health Care Stocks Moving In Thursday's Pre-Market SessionBenzinga Insights - May 11, 2023, 9:06AM
- Why Muscle Maker Shares Are Trading Higher By 24%; Here Are 20 Stocks Moving PremarketLisa Levin - May 11, 2023, 8:22AM
Wednesday, May 10, 2023
Monday, May 08, 2023
Friday, May 05, 2023
Thursday, May 04, 2023
Friday, April 28, 2023
Thursday, April 27, 2023
Tuesday, April 25, 2023
- Dow Dips Over 300 Points; McDonald's Beats Q1 ExpectationsLisa Levin - Apr 25, 2023, 2:30PM
- Why GE HealthCare Technologies Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionLisa Levin - Apr 25, 2023, 1:33PM
- Stocks That Hit 52-Week Lows On TuesdayBenzinga Insights - Apr 25, 2023, 1:33PM
- 12 Health Care Stocks Moving In Tuesday's Intraday SessionBenzinga Insights - Apr 25, 2023, 1:31PM
- Crude Oil Down Over 2%; General Motors Raises Profit OutlookLisa Levin - Apr 25, 2023, 12:04PM
- Vyant Bio shares are trading lower after the company announced a voluntary Nasdaq delisting and SEC deregistration.Benzinga Newsdesk - Apr 25, 2023, 10:53AM
- 12 Health Care Stocks Moving In Tuesday's Pre-Market SessionBenzinga Insights - Apr 25, 2023, 9:06AM
Monday, April 24, 2023
Monday, April 10, 2023
Tuesday, March 28, 2023
Tuesday, February 14, 2023
Friday, February 03, 2023
- 12 Health Care Stocks Moving In Friday's Intraday SessionBenzinga Insights - Feb 3, 2023, 12:31PM
- Vyant Bio shares are trading lower after HC Wainwright & Co downgraded the stock from Buy to Neutral.Benzinga Newsdesk - Feb 3, 2023, 11:47AM
- Benzinga's Top Ratings Upgrades, Downgrades For February 3, 2023Benzinga Insights - Feb 3, 2023, 10:00AM
- HC Wainwright & Co. Downgrades Vyant Bio to NeutralBenzinga Newsdesk - Feb 3, 2023, 9:28AM
- Vyant Bio Says Continuing To Explore Strategic AlternativesBenzinga Newsdesk - Feb 3, 2023, 6:07AM
- Vyant Bio Plans To Cut Jobs To Preserve Cash; CEO John Roberts & Chief Scientific Officer Robert Fremeau Agree To Step DownBenzinga Newsdesk - Feb 3, 2023, 6:06AM
Thursday, January 12, 2023
Friday, January 06, 2023
- Why Spruce Biosciences Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Friday's Mid-Day SessionLisa Levin - Jan 6, 2023, 1:16PM
- 12 Health Care Stocks Moving In Friday's Pre-Market SessionBenzinga Insights - Jan 6, 2023, 8:05AM
- Why Graphite Bio Shares Are Trading Lower By 50%; Here Are 20 Stocks Moving PremarketLisa Levin - Jan 6, 2023, 8:00AM
Thursday, January 05, 2023
- 12 Health Care Stocks Moving In Thursday's After-Market SessionBenzinga Insights - Jan 5, 2023, 4:30PM
- Why ABVC BioPharma Shares Are Trading Higher By 129%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionLisa Levin - Jan 5, 2023, 1:01PM
- 12 Health Care Stocks Moving In Thursday's Intraday SessionBenzinga Insights - Jan 5, 2023, 12:30PM
- On Dec 30, 2022, Vyant Bio's Vivopharm Pty, Ltd, A Wholly Owned Subsidiary Of Co, Entered Into A Share Purchase Agreement With Sabine Brandt To Which Vivopharm Sold The Entirety Of The Company's Remaining Vivopharm BusinessBenzinga Newsdesk - Jan 5, 2023, 9:32AM
- Vyant Bio shares are trading higher after the company engaged LifeSci Capital as its advisor to explore strategic alternatives.Benzinga Newsdesk - Jan 5, 2023, 8:27AM
- 12 Health Care Stocks Moving In Thursday's Pre-Market SessionBenzinga Insights - Jan 5, 2023, 8:05AM
- Why Geron Shares Are Trading Lower By 13%; Here Are 20 Stocks Moving PremarketLisa Levin - Jan 5, 2023, 8:01AM
- Walgreens, Constellation Brands And 3 Stocks To Watch Heading Into ThursdayLisa Levin - Jan 5, 2023, 4:03AM
Wednesday, January 04, 2023
- Why Vyant Bio Shares Are Soaring After HoursAdam Eckert - Jan 4, 2023, 4:38PM
- 12 Health Care Stocks Moving In Wednesday's After-Market SessionBenzinga Insights - Jan 4, 2023, 4:30PM
- Vyant Bio shares are trading higher after the company engaged LifeSci Capital as its advisor to explore strategic alternatives.Benzinga Newsdesk - Jan 4, 2023, 4:19PM
- Vyant Bio Engages LifeSci Capital To Explore Strategic AlternativesMichael Horton - Jan 4, 2023, 4:18PM